BioSpace News Archive

Veradigm Inc. announced today it has reaffirmed the estimated, unaudited ranges for fiscal 2023 of GAAP Revenue, Adjusted EBITDA, and Non-GAAP diluted earnings per share that it provided on January 10, 2024, in the Company’s Form 8-K filed on January 10, 2024, and initially reaffirmed on February 27, 2024.

AstraZeneca today announced the initiation of a Phase III trial to investigate the potential effect of triple-combination inhaled therapy BREZTRI AEROSPHERE®.

Dyne Therapeutics, Inc. announced that management is scheduled to participate in a fireside chat at the Stifel 2024 Virtual CNS Days on Wednesday, March 20, 2024 at 8:30 a.m. ET.

LGM Pharma announced a significant enhancement of its capabilities: a 50% expansion and an investment exceeding $2 million in its standalone offering for Analytical Testing Services alongside the introduction of new suppository manufacturing capabilities to its contract development and manufacturing portfolio.

Crescita Therapeutics Inc., a growth-oriented, innovation-driven Canadian commercial dermatology company, reported its financial results for the fourth quarter and fiscal year ended December 31, 2023.

Alnylam Pharmaceuticals, Inc. announced the launch of the Family Health History Road Trip, its program designed to encourage conversations between family members about their health history so they can discuss with their doctor to better understand their risk for developing an inherited disease like hereditary ATTR amyloidosis.

Recce Pharmaceuticals Ltd announced a poster presentation of data from a Phase 1 study evaluating the safety of its lead asset, RECCE® 327, at the American Society for Clinical Pharmacology & Therapeutics 2024 Annual Meeting taking place March 27-29, 2024, in Colorado Springs, Colorado.

YolTech Therapeutics, a biotech company pioneering in in vivo gene editing therapies, today announced participation in TIDES Asia 2024, March 19th to 21st, 2024, at the Westin Miyako Kyoto in Kyoto, Japan.

Waters Corporation announced a new accessory for its TA Instruments Discovery Hybrid Rheometers designed to enable simultaneous electrical impedance and rheological measurements, a critical capability for scientists working on new battery formulations.

Sandoz, the global leader in generic and biosimilar medicines, announced net sales for the fourth quarter and results for the full year ended December 31, 2023.